AB InBev Isn't Defending Beer. It's Recoding the Drinking Occasion.

The standard narrative for the last three years has been that alcohol is in structural decline. Younger consumers drink less. GLP-1s suppress demand. Wellness culture punishes the calorie cost. Investors have discounted the big brewers and spirits houses accordingly. On May 5, AB InBev published Q1 2026 results and quietly told a different story. AB InBev is not defending a shrinking category. It is recoding the drinking occasion entirely.

The world's largest brewer posted $15.27 billion in revenue (+5.8% organic), record Q1 underlying EPS of $0.97 (+20.8%), Corona +16% revenue and +14% volume outside its home market, and 8.2% revenue growth across the megabrand portfolio. The headline is the EPS number. The strategic story sits two layers down — and it forces a complete reread of every brewer, distiller and adjacent beverage operator's defensive narrative.

The 27% number that breaks the slump thesis

No-alcohol beer revenue grew 27% in the quarter. Beyond Beer — the ready-to-drink portfolio — grew 37%. Those are growth rates that look pulled from a venture-backed beverage start-up, not from a brewer with roots going back to the 1850s. But the line that should reshape the sector debate sits in the company's own commentary: roughly 60% of AB InBev's no-alcohol volume is coming from new drinking occasions and new consumers. That single statistic dismantles the alcohol-slump narrative as it has been written for the last three years. If most of the no-alcohol volume were trade-down from beer drinkers cutting back, this would still be a defensive story. It is not. It is incremental demand.

So what? The category is not shrinking. The drinking occasion is expanding. AB InBev has built two products against the same global brand machine — beer for the existing occasion, no-alc for the new one — and is harvesting both.

Where the growth is showing up

Corona is the clearest case. Beyond Mexico, Corona delivered +16% revenue and +14% volume in Q1, with double-digit volume growth in 32 markets. Corona Cero — launched globally against the Paris Olympics in 2024 — is now growing strong double-digits worldwide and is the primary lever inside the no-alc revenue line. Two product profiles, one consumer trust asset, two consumption occasions. The result: beer volume +1.2%, revenue per hectolitre +4.5%, and the megabrand operating model out-performing nine quarters of category-decline commentary.

In the US, Michelob ULTRA Zero is driving the same pattern — health-positioned, low-calorie, alcohol-free — slotting into morning runs, weekday lunches and other moments traditional beer was never invited to. This is brand equity used as a permission slip to enter occasions where full-strength beer would have been excluded.

Why this rewrites the sector debate

Heineken 0.0 has already shown the pattern at a smaller scale — over 4% of the parent portfolio and growing at a 10% CAGR since 2017. Molson Coors' Blue Moon Non-Alcoholic line is growing 25%. Diageo paid for a controlling stake in Seedlip in 2024 and is now extending Captain Morgan 0.0 and other zero-proof variants. Pernod Ricard has stood up a dedicated no-alc production line. The companies that read the trend as defence built defensive products. AB InBev read it as occasion-creation and built occasion-creation products. The Q1 print just made the difference visible at financial scale.

For the investor, the implication is sharp. Operators that can attach their megabrands to new occasions are buying optionality the volume-only producers cannot. Megabrand depth, not brand count, is the strategic asset. AB InBev now sits inside two demand curves — established beer and emerging no-alc — using one marketing engine and one trust asset per market.

The next 90 days

Q2 2026 results land in late July or early August. The market will be looking for whether the no-alc and Beyond Beer growth rates compound, decelerate, or come at the expense of beer pricing. If non-alc and beer both stay in growth, the implied multiple on AB InBev compresses the discount the sector has carried since 2022. If the gap narrows — and it should — read the rerating as a category-wide signal rather than a single-name story. Heineken H1 (early August) and Diageo full-year (August) become the cross-checks.

For operators planning category strategy, the assumption that no-alc cannibalises beer needs to be retired. The assumption that premium full-strength plus zero-proof widens the addressable market is now the better base case. Plan your portfolio against demand expansion, not demand defence. The next 18 months will reward operators running that thesis, not those still pricing in structural decline.

Related Zenith research: US THC Beverage Market Report 2026 — independent sizing of the US hemp-derived THC beverage category and the regulatory scenarios shaping drinking occasions.